Aralez Bio
Proprietary enzymatic and biocatalysis technology.
About
Aralez Bio is leveraging Nobel Prize winning technology from Caltech for biosynthesis of non-canonical Amino Acids for use in biologic medicines such as GLP-1 agonists. Aralez’s technology surpasses existing chemical synthesis methods across the board – more variety, better scale-ability, lower cost, and no toxic byproducts.
- Location: San Francisco, CA
- Paladin Initial Investment Date: August 2024